ATU

Amwins Forms National Transportation Underwriters

Retrieved on: 
Wednesday, May 1, 2024
Transport, ATU, Insurance, Legacy, ANTU, Organization, Renewable energy

CHARLOTTE, N.C., May 1, 2024 /PRNewswire/ -- Amwins today announced the formation of Amwins National Transportation Underwriters (ANTU). This entity brings together the expertise of Amwins Transportation Underwriters (ATU) and National Truck Underwriting Managers (NTUM), two long-standing MGAs dedicated to the transportation space who underwrite a combined $250M+ in annual premium.

Key Points: 
  • CHARLOTTE, N.C., May 1, 2024 /PRNewswire/ -- Amwins today announced the formation of Amwins National Transportation Underwriters (ANTU).
  • This entity brings together the expertise of Amwins Transportation Underwriters (ATU) and National Truck Underwriting Managers (NTUM), two long-standing MGAs dedicated to the transportation space who underwrite a combined $250M+ in annual premium.
  • As a single operating company, Amwins National Transportation Underwriters will provide clients with nationwide access to almost a dozen binding markets and a growing list of specialty transportation programs.
  • The formation of Amwins National Transportation Underwriters reinforces Amwins' commitment to transportation, driving innovation and serving up solutions that meet the needs of a vital and evolving industry.

OFL urges Mayor Andrea Horwath to oppose the privatization of Hamilton LRT

Retrieved on: 
Tuesday, April 23, 2024
LRT, Municipal council, City, Safety, ATU, Privatization, Partnership, Hamilton Street Railway, Hamilton City Council (Ontario), Amalgamated Transit Union, O-Train, Line 5 Eglinton, Government, HSR, Airline

HAMILTON, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- The Ontario Federation of Labour (OFL) is calling on Mayor Andrea Horwath to uphold the public interest by voting against the proposed privatization of Hamilton’s Light Rail Transit (LRT) line.

Key Points: 
  • HAMILTON, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- The Ontario Federation of Labour (OFL) is calling on Mayor Andrea Horwath to uphold the public interest by voting against the proposed privatization of Hamilton’s Light Rail Transit (LRT) line.
  • On April 24, the Hamilton City Council will vote on a 10-year public-private partnership, aimed at outsourcing operations and maintenance to a private contractor.
  • “Given the proven capabilities and track record of the HSR and ATU, there is absolutely no justification for privatizing the Hamilton LRT,” Walton added.
  • The OFL reminds Hamilton City Councillors of their 2017 commitment to keep the LRT public under the HSR’s operation.

GenSight Biologics Reports Cash Position as of March 31, 2024, and Provides Business Update

Retrieved on: 
Thursday, April 4, 2024
Health, Neurology, Genetics, Pharmaceutical, Optical, Biotechnology, PIII, URD, Three-body problem, Patient, Good manufacturing practice, Health care, EAP, Acquisition, EMA, Risk, Chapter, GMP, MHRA, DS, ATU, AMF, Good, Phase, AAP, Ethics, FDA, Amendment, AAC, Medication, Pharmaceutical industry

GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position as of March 31, 2024 and provided a business update.

Key Points: 
  • GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position as of March 31, 2024 and provided a business update.
  • Once the AAC/AAP program resumes, the Company estimates that the cash runway would be extended to the end of Q1 2025.
  • GenSight successfully manufactured two Drug Substance (DS) batches of LUMEVOQ® meeting Good Manufacturing Practice (GMP) standards in September and November 2023.
  • As of March 31, 2024, GenSight Biologics’ number of outstanding shares was 78,370,724 ordinary shares.

GenSight Biologics Reports Full Year 2023 Consolidated Financial Results

Retrieved on: 
Friday, March 22, 2024
Health, Neurology, Genetics, Pharmaceutical, Optical, Biotechnology, Control, URD, Three-body problem, Safety, Partnership, Research, CIR, ANSM, CMC, EMA, BofA Securities, Risk, Chapter, MHRA, Clinical trial, European Investment Bank, ATU, AMF, Workforce, EIB, AAP, Marketing, FDA, Amendment, AAC, Cryptocurrency

From 2022 to 2023, the Company's research and development expenses remained stable, at €19.3 million in 2022 and €19.4 million in 2023.

Key Points: 
  • From 2022 to 2023, the Company's research and development expenses remained stable, at €19.3 million in 2022 and €19.4 million in 2023.
  • The Company's general and administrative expenses also remained stable and amounted to €5.4 million in 2022 and 2023.
  • The weighted average number of shares outstanding increased from 46.3 million in 2022 to 48.3 million in 2023, thereby reducing the loss per share from (€0.54) in 2023 to (€0.60) in 2023.
  • GenSight Biologics will report its cash position as of March 31, 2024 on April 4 2024.

Ontario workers rally against Ford’s corruption, closures and cost-of-living crisis

Retrieved on: 
Saturday, February 3, 2024
Policy, Amalgamated Transit Union, Life, Public, Local, ATU, Social media, SOS, Niagara Region, Privatization, Death, Ford, Student, Movement

The rally highlighted the Ford government’s record of corruption, closures, and cost-of-living crisis, and featured labour and community speakers from the Niagara Region and across Ontario.

Key Points: 
  • The rally highlighted the Ford government’s record of corruption, closures, and cost-of-living crisis, and featured labour and community speakers from the Niagara Region and across Ontario.
  • “If ever there was a ‘best-before’ date for governments, this one is well past it,” said Jackie Taylor, Executive Vice-President of the OFL.
  • “Almost six years after Ford’s election, life in Ontario is harder and more expensive for workers and their families.”
    Rally speakers condemned Ford’s privatization agenda and its devastating impact on public services, especially health care.
  • The Ontario Federation of Labour represents 54 unions and one million workers in Ontario.

Amwins Underwriting Announces New Carrier Partner for Trucking Programs

Retrieved on: 
Thursday, February 1, 2024
ATU, Transport, Lancer, Insurance

CHARLOTTE, N.C., Feb. 1, 2024 /PRNewswire/ -- Amwins Underwriting today announced a strategic collaboration with Lancer Insurance Company, the commercial auto division of Core Specialty, as a new carrier relationship to enhance two key trucking programs provided through Amwins Transportation Underwriters (ATU). The business will be written on StarStone National Insurance Company paper backed by Lancer's industry-leading claims handling.

Key Points: 
  • CHARLOTTE, N.C., Feb. 1, 2024 /PRNewswire/ -- Amwins Underwriting today announced a strategic collaboration with Lancer Insurance Company, the commercial auto division of Core Specialty , as a new carrier relationship to enhance two key trucking programs provided through Amwins Transportation Underwriters (ATU).
  • "We are excited with this new exclusive relationship to provide coverage across ATU's portfolio of trucking programs," said Ryan Armijo, president at Amwins Underwriting.
  • Amwins Transportation Underwriters is a managing general agency and wholesale insurance brokerage that specializes in the trucking / transportation industry.
  • Since 1957, ATU's team has provided comprehensive trucking insurance services to short and long-haul trucking operations and now manages a portfolio that includes contractors, limousine operators, environmental haulers and more.

InfiRay® Debuts at WIN EURASIA 2023

Retrieved on: 
Wednesday, June 7, 2023
Metallurgy, Istanbul Fair Center Yeşilköy, Red Dot, SF6, Electricity, Volatile organic compound, WIN, Chemical engineering, ATU, CH4, Television

YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred to as " InfiRay ®" below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.

Key Points: 
  • YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred to as " InfiRay ®" below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.
  • InfiRay ® presented its innovative technologies and highlighted thermal imaging products in hall 4 booth A960 at Istanbul Expo Center, Turkey.
  • InfiRay showed us a series of infrared thermal imaging devices, bringing systematic infrared application solutions to the industrial manufacturing field.
  • Moreover, InfiRay also brought gas thermal imaging cameras, which can not only detect VOCs gases such as CH4, but also SF6 required for electricity.

InfiRay® Debuts at WIN EURASIA 2023

Retrieved on: 
Wednesday, June 7, 2023
Metallurgy, Istanbul Fair Center Yeşilköy, Red Dot, SF6, Electricity, Volatile organic compound, WIN, Chemical engineering, ATU, CH4, Printed circuit board

YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred to as " InfiRay ®" below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.

Key Points: 
  • YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred to as " InfiRay ®" below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.
  • InfiRay ® presented its innovative technologies and highlighted thermal imaging products in hall 4 booth A960 at Istanbul Expo Center, Turkey.
  • InfiRay showed us a series of infrared thermal imaging devices, bringing systematic infrared application solutions to the industrial manufacturing field.
  • Moreover, InfiRay also brought gas thermal imaging cameras, which can not only detect VOCs gases such as CH4, but also SF6 required for electricity.

Apollo Intelligence Further Expands Its Commercial Focus on Tech-Enabled Healthcare Insights with Key Executive Hires

Retrieved on: 
Wednesday, April 12, 2023
Data Management, Technology, Professional Services, Other Communications, Health, General Health, Marketing, Advertising, Communications, Software, Other Professional Services, Intelligence, Approximation error, Disease, Clarivate, Stevie Awards, Investment, Frazier Healthcare Partners, ESMO, COVID-19, Recognition, Research, Tschudi, HCP, ASCO, National List, RSV, Acquisition, Allscripts, Swedish Business Awards, ATU, DRG, Growth, SHG, Mental health, Management, Pharmaceutical industry

Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, capped a strong 2022 by expanding its commercial leadership with the addition of two key executives.

Key Points: 
  • Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, capped a strong 2022 by expanding its commercial leadership with the addition of two key executives.
  • “Life science firms rely on our InCrowd and Survey Healthcare Global brands for real-time market insights from our global healthcare professional panel to inform their business decisions.
  • He joins Apollo from Parata Systems, the medication robotic dispensing company where Schudy led sales, marketing, and customer success teams.
  • Investments in panel expansion and engagement that elevated Apollo to one of the largest providers of global healthcare audiences.

Trinity Life Sciences Institutes a Formal Performance Tracking Center of Excellence

Retrieved on: 
Thursday, March 16, 2023
Software, Research, Professional Services, Pharmaceutical, Data Management, Technology, Data Analytics, Science, Marketing, Communications, Other Science, Health, Real-World Evidence, COE, Partnership, Center of excellence, Insight, Patient, Strategic Advisory Board for Intellectual Property Policy, ATU, RWE, Perception, Survey methodology

Trinity Life Sciences , a leader in global life sciences commercialization solutions, announces the creation of Trinity Performance Tracking , a new Center of Excellence (COE) that focuses on a comprehensive approach to stakeholder perception tracking and integrates primary and secondary data to view the total context.

Key Points: 
  • Trinity Life Sciences , a leader in global life sciences commercialization solutions, announces the creation of Trinity Performance Tracking , a new Center of Excellence (COE) that focuses on a comprehensive approach to stakeholder perception tracking and integrates primary and secondary data to view the total context.
  • Trinity Performance Tracking focuses on dynamic assessment of brand optimization—dynamic because it is enabled by technology and identifies areas of disconnect to provide insights on course correction.
  • The new COE provides advisory services that allow life sciences companies to:
    Integrate datasets from different sources at the physician level, including Real-World Evidence (RWE), calls and promotional data
    “Stakeholder perception research is an incredible source of actionable insight,” explained Lara Lyeth , Principal in the Strategic Advisory practice at Trinity Life Sciences.
  • “Trinity’s Performance Tracking COE offers trackers that are essentially diagnostic tools to optimize brand strategy and commercial potential.”
    A webinar, Far from Routine: Performance Tracking as a Source of Powerful Insight, on April 27 will discuss stakeholder perception tracking research as an often overlooked strategic and tactical input to optimizing a brand’s commercial performance.